Browse studies

Find your next paid study

4,344 recruiting studies matching your filters

Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department: a Randomized Controlled Study

The goal of this clinical trial is to learn if buprenorphine can treat pain in older adults who have broken bones. The main questions it aims to answer are: I…

Fracture

Estimated

~$150 – $3,000

Actual pay is set by the research site.

The Cooper Health SystemNCT07430345

Observational

Experimental Effects of Light And Content From Evening Screen Media Use On Children's Sleep, Executive Functioning, And Emotion Regulation

The proposed project aims to disentangle the impact of evening light exposure emitted from tablet devices from the impact of arousing media content on children…

SleepCircadian RhythmExecutive Function+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Baylor College of MedicineNCT06192745

Phase 2

Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications in People With T1D (Precision T1D Platform)

Breakthrough T1D has awarded support for a joint University of Michigan-Oregon Health \& Science University Center of Excellence (CoE) to address cardio-renal …

Type 1 DiabetesT1D Heart FailureCardio-renal Vascular Function and Failure+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Oregon Health and Science UniversityNCT07594145

Phase 2

A Pilot Study of the Role of an Antimicrobial Herbal Formulation (Biocidin REMOVE) for the Management of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Irritable Bowel Syndrome (IBS)

The goal of this clinical trial is to learn if an herbal supplement called Biocidin REMOVE can clear small intestinal bacterial overgrowth (SIBO) in adults wit…

Irritable Bowel Syndrome (IBS)Small Intestinal Bacterial Overgrowth Syndrome (SIBO)

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Johns Hopkins UniversityNCT07768267

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i (ACHIEVE-SGLT2i) Registry

This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital hea…

Adult Congenital Heart DiseaseCongenital Heart DiseaseSystemic Right Ventricle+5 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Leiden University Medical CenterNCT06932081

Phase 1

The Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) and CCR4 for Relapsed/Refractory CD30+ Hodgkin s Lymphoma

Despite the progress in the therapy, Hodgkin's Lymphoma (HL) remains fatal for more than 15% of patients. Even in patients who are cured, the morbidity of ther…

Hodgkin LymphomaRelapseRefractory

Estimated

~$150 – $3,000

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT06090864

Phase 1

A Phase Ib Study of Botensilimab Plus Balstilimab and Fasting-Mimicking Diet (FMD) Plus Vitamin C in Patients With KRAS-Mutant Metastatic Colorectal Cancer

This phase Ib trial tests the safety, side effects, and effectiveness of botensilimab, and balstilimab in combination with a fasting mimicking diet and high do…

Metastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v8

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Southern CaliforniaNCT06336902

Phase 3

An Extension Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig, Including Inhaled Corticosteroid Withdrawal, in Adults With Chronic Obstructive Pulmonary Disease (COPD) Who Completed Studies EFC18243 or EFC18244

This is an open-label, Phase 3, long-term safety extension study including participants of previous lunsekimig clinical trials with inadequately controlled chr…

Chronic Obstructive Pulmonary Disease

Estimated

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT07793409

Phase 1

A Phase I Study of Bivalent CD79b and CD19 Directed CAR T Cells in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma

This research study involves the study of CD79b-19 CAR T cells for treating people with relapsed/refractory Non-Hodgkin Lymphoma and to understand the side eff…

Non-hodgkin LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+7 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Marcela V. Maus, M.D.,Ph.D.NCT06026319

Observational

Application of Virtual Reality Technology to Treatment of Social Anxiety

The purpose of this study is to compare CBT VR exposure + VR social skills treatment to CBT Imaginal exposure + mindfulness, in reducing the severity of social…

Autism Spectrum DisorderSocial Anxiety Disorder

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT06845488

Observational

Oscillating Lung Expansion (OLE) Therapy in the Bronchiectasis Patients (BE) Home Care Study Protocol

The study will examine how the performance of Oscillating Lung Expansion (OLE) therapy affects the respiratory health of patients with Bronchiectasis (BE). Th…

BronchiectasisPulmonary Exacerbation

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Delve HealthNCT06926881

Phase 2

DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study

The goal of this trial is to see if active surveillance monitoring and hormonal therapy in patients diagnosed with ductal cell carcinoma in situ (DCIS), an ear…

Ductal Carcinoma in Situ

Estimated

~$75 – $3,000

Actual pay is set by the research site.

QuantumLeap Healthcare CollaborativeNCT06075953